Michael Lawrence Dougan, M.D.,Ph.D.
This page shows the publications co-authored by Michael Dougan and Yousef Badran.
Immune-related adverse events: what we've learned and where we're heading. Expert Rev Anticancer Ther. 2020 09; 20(9):727-730.
Immune checkpoint inhibitor-associated celiac disease. J Immunother Cancer. 2020 06; 8(1).
Concurrent therapy with immune checkpoint inhibitors and TNFa blockade in patients with gastrointestinal immune-related adverse events. J Immunother Cancer. 2019 08 22; 7(1):226.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.